Abstract
Dori vositalari inson salomatligini saqlash, kasalliklarni davolash va oldini olishda muhim ahamiyat kasb etadi. Biroq ularni to‘g‘ri va xavfsiz qo‘llash zarur, aks holda salomatlik uchun jiddiy xavflar tug‘ilishi mumkin. Retsept tizimi dorilarning shifokor nazorati ostida to‘g‘ri qo‘llanishini ta’minlashga xizmat qiladi. Ushbu maqolada retseptlarning ahamiyati, ularning tuzilishi va dorilarning retseptsiz (OTC), retsept bo‘yicha va nazorat ostidagi turlari tahlil qilinadi. Shuningdek, dori xavfsizligi, litsenziyalash va soxta dorilarning oldini olish masalalari ham yoritiladi. Tadqiqot dorilarni belgilangan qoidalarga muvofiq qabul qilishning muhimligini, davolash samaradorligini oshirish, nojo‘ya ta’sirlarni kamaytirish va aholi salomatligini himoya qilish zarurligini ta’kidlaydi.
References
1. Jahon sog‘liqni saqlash tashkiloti (WHO). (2023). Essential Medicines and Health Products. Retrieved from https://www.who.int
2. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. (2023). Dori vositalari va farmatsevtika qonunchiligi. Tashkent: O‘zbekiston tibbiyot nashriyoti.
3. European Medicines Agency (EMA). (2022). Regulation of Prescription and Over-the-Counter Medicines in Europe. Brussels: EMA Publications.
4. United States Food and Drug Administration (FDA). (2021). Drug Approval Process and Safety Regulations. Washington, DC: FDA.
5. O‘zbekiston Respublikasi Oliy Majlisi. (2023). Dori vositalari to‘g‘risidagi qonun. Retrieved from www.lex.uz
6. British Pharmacopoeia. (2023). Standards for Drug Safety and Efficacy. London: UK Medicines & Healthcare Products Regulatory Agency.
7. Pharmacological Review Journal. (2022). The Role of Prescriptions in Preventing Medication Misuse. 45(3), 102-115.
8. O‘zbekiston farmakologiya instituti. (2021). Dorilarning ta’siri va nojo‘ya ta’sirlar bo‘yicha tadqiqotlar. Tashkent: Ilmiy nashr.
9. World Bank. (2022). Improving Access to Essential Medicines in Developing Countries. Washington, DC: World Bank.
10. International Pharmaceutical Federation (FIP). (2023). Pharmacy Education and Drug Safety Practices. The Hague: FIP Publications.